Sandeep Vasant More

2.2k total citations
28 papers, 1.8k citations indexed

About

Sandeep Vasant More is a scholar working on Molecular Biology, Neurology and Neurology. According to data from OpenAlex, Sandeep Vasant More has authored 28 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Neurology and 8 papers in Neurology. Recurrent topics in Sandeep Vasant More's work include Neuroinflammation and Neurodegeneration Mechanisms (9 papers), Parkinson's Disease Mechanisms and Treatments (8 papers) and Medicinal Plants and Neuroprotection (4 papers). Sandeep Vasant More is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (9 papers), Parkinson's Disease Mechanisms and Treatments (8 papers) and Medicinal Plants and Neuroprotection (4 papers). Sandeep Vasant More collaborates with scholars based in South Korea, India and China. Sandeep Vasant More's co-authors include Dong‐Kug Choi, Hemant Kumar, Byung-Wook Kim, In‐Su Kim, In Su Kim, Sushruta Koppula, Shyam Sunder Sharma, Ravinder K. Kaundal, Pramod Kumar and Sung‐Hwa Yoon and has published in prestigious journals such as International Journal of Molecular Sciences, Molecules and Nutrients.

In The Last Decade

Sandeep Vasant More

27 papers receiving 1.8k citations

Peers

Sandeep Vasant More
Zhizhong Ma China
Byung-Wook Kim South Korea
Sidharth Mehan India
Abdullah Shafique Ahmad United States
Hareram Birla India
Seema Yousuf United States
Sofiyan Saleem United States
Bimla Nehru India
Muzamil Ahmad India
Hee Ra Park South Korea
Zhizhong Ma China
Sandeep Vasant More
Citations per year, relative to Sandeep Vasant More Sandeep Vasant More (= 1×) peers Zhizhong Ma

Countries citing papers authored by Sandeep Vasant More

Since Specialization
Citations

This map shows the geographic impact of Sandeep Vasant More's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandeep Vasant More with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandeep Vasant More more than expected).

Fields of papers citing papers by Sandeep Vasant More

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandeep Vasant More. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandeep Vasant More. The network helps show where Sandeep Vasant More may publish in the future.

Co-authorship network of co-authors of Sandeep Vasant More

This figure shows the co-authorship network connecting the top 25 collaborators of Sandeep Vasant More. A scholar is included among the top collaborators of Sandeep Vasant More based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandeep Vasant More. Sandeep Vasant More is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
More, Sandeep Vasant & Dong‐Kug Choi. (2017). Neuroprotective Role of Atractylenolide-I in an In Vitro and In Vivo Model of Parkinson’s Disease. Nutrients. 9(5). 451–451. 39 indexed citations
3.
More, Sandeep Vasant & Dong‐Kug Choi. (2017). Atractylenolide-I Protects Human SH-SY5Y Cells from 1-Methyl-4-Phenylpyridinium-Induced Apoptotic Cell Death. International Journal of Molecular Sciences. 18(5). 1012–1012. 19 indexed citations
4.
Kim, Byung-Wook, Sandeep Vasant More, Jae‐Hwan Kwak, et al.. (2016). A novel synthetic compound MCAP suppresses LPS-induced murine microglial activation in vitro via inhibiting NF-kB and p38 MAPK pathways. Acta Pharmacologica Sinica. 37(3). 334–343. 32 indexed citations
5.
Kim, Byung-Wook, Sushruta Koppula, Hemant Kumar, et al.. (2015). α-Asarone attenuates microglia-mediated neuroinflammation by inhibiting NF kappa B activation and mitigates MPTP-induced behavioral deficits in a mouse model of Parkinson's disease. Neuropharmacology. 97. 46–57. 106 indexed citations
6.
More, Sandeep Vasant & Dong‐Kug Choi. (2015). Promising cannabinoid-based therapies for Parkinson’s disease: motor symptoms to neuroprotection. Molecular Neurodegeneration. 10(1). 17–17. 99 indexed citations
7.
More, Sandeep Vasant, Ju‐Young Park, Byung-Wook Kim, et al.. (2015). Anti-neuroinflammatory effects of DPTP, a novel synthetic clovamide derivative in in vitro and in vivo model of neuroinflammation. Brain Research Bulletin. 112. 25–34. 19 indexed citations
8.
Kumar, Hemant, Byung-Wook Kim, Sandeep Vasant More, et al.. (2014). β-Asarone (cis-2,4,5-trimethoxy-1-allyl phenyl), attenuates pro-inflammatory mediators by inhibiting NF-κB signaling and the JNK pathway in LPS activated BV-2 microglia cells. Food and Chemical Toxicology. 72. 265–272. 35 indexed citations
9.
10.
Banerjee, Abhisek, Lakshminarayana Narayana, Srinivas Gullapalli, et al.. (2013). Discovery of benzo[d]imidazo[5,1-b]thiazole as a new class of phosphodiesterase 10A inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(24). 6747–6754. 23 indexed citations
11.
Kumar, Hemant, Sushruta Koppula, In‐Su Kim, et al.. (2013). Nuclear Factor Erythroid 2 - Related Factor 2 Signaling in Parkinson Disease: A Promising Multi Therapeutic Target Against Oxidative Stress, Neuroinflammation and Cell Death. CNS & Neurological Disorders - Drug Targets. 11(8). 1015–1029. 67 indexed citations
12.
More, Sandeep Vasant, et al.. (2013). Advances in Neuroprotective Ingredients of Medicinal Herbs by Using Cellular and Animal Models of Parkinson’s Disease. Evidence-based Complementary and Alternative Medicine. 2013. 1–15. 38 indexed citations
13.
More, Sandeep Vasant, et al.. (2013). Strategic Selection of Neuroinflammatory Models in Parkinson's Disease: Evidence from Experimental Studies. CNS & Neurological Disorders - Drug Targets. 12(5). 680–697. 29 indexed citations
14.
More, Sandeep Vasant, Ju‐Young Park, Byung-Wook Kim, et al.. (2013). Anti-neuroinflammatory Activity of a Novel Cannabinoid Derivative by Inhibiting the NF-κB Signaling Pathway in Lipopolysaccharide-Induced BV-2 Microglial Cells. Journal of Pharmacological Sciences. 121(2). 119–130. 25 indexed citations
15.
Kumar, Hemant, In‐Su Kim, Sandeep Vasant More, Byung-Wook Kim, & Dong‐Kug Choi. (2013). Natural product-derived pharmacological modulators of Nrf2/ARE pathway for chronic diseases. Natural Product Reports. 31(1). 109–139. 297 indexed citations
16.
Kumar, Hemant, et al.. (2013). Traditional Korean East Asian Medicines and Herbal Formulations for Cognitive Impairment. Molecules. 18(12). 14670–14693. 30 indexed citations
17.
Koppula, Sushruta, et al.. (2012). Recent Updates in Redox Regulation and Free Radical Scavenging Effects by Herbal Products in Experimental Models of Parkinson’s Disease. Molecules. 17(10). 11391–11420. 32 indexed citations
18.
More, Sandeep Vasant, Sushruta Koppula, In‐Su Kim, et al.. (2012). The Role of Bioactive Compounds on the Promotion of Neurite Outgrowth. Molecules. 17(6). 6728–6753. 76 indexed citations
19.
Kumar, Hemant, Sandeep Vasant More, Byung-Wook Kim, et al.. (2012). The Role of Free Radicals in the Aging Brain and Parkinson’s Disease: Convergence and Parallelism. International Journal of Molecular Sciences. 13(8). 10478–10504. 168 indexed citations
20.
Kumar, Pramod, Ravinder K. Kaundal, Sandeep Vasant More, & Shyam Sunder Sharma. (2008). Beneficial effects of pioglitazone on cognitive impairment in MPTP model of Parkinson's disease. Behavioural Brain Research. 197(2). 398–403. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhizhong Ma Breakdown of academic impact, for papers by Byung-Wook Kim Breakdown of academic impact, for papers by Sidharth Mehan Breakdown of academic impact, for papers by Abdullah Shafique Ahmad Breakdown of academic impact, for papers by Hareram Birla Breakdown of academic impact, for papers by Seema Yousuf Breakdown of academic impact, for papers by Sofiyan Saleem Breakdown of academic impact, for papers by Bimla Nehru Breakdown of academic impact, for papers by Muzamil Ahmad Breakdown of academic impact, for papers by Hee Ra Park
Rankless by CCL
2026